This 2010 report describes the many programs White Bison, Inc., has developed to prevent addiction and create individual recovery and resiliency in American Indian and Alaska Native Communities including the Wellbriety model, the concept of the Healing Forest, and the Firestarter peer
Evidence Category: Proven
The intervention or program has demonstrated effectiveness through two or more rigorous, well-conducted studies or program evaluations where the preponderance of evidence indicates significant positive change in a clearly identified outcome or process measure AND the intervention or program has been implemented and evaluated in real-world settings with documented and sustained benefits to individuals or communities.
Policy Evaluation: Substance Use Disorders
Source: Oregon Health Authority
This 2019 review from Oregon’s Drug Use Research & Management Program examined whether removing Medicaid prior authorization requirements for medication assisted treatment for individuals with opioid use
Jail-Based Medication-Assisted Treatment: Promising Practices, Guidelines, and Resources for the Field
Source: National Commission on Correctional Health Care
This 2018 publication from the National Sheriff’s Association and the National Commission on Correctional Health Care provides guidance on how to create and manage a medication assisted treatment program
Medications for Opioid Use Disorder Save Lives: Consensus Study Report – Highlights
Source: National Academies of Science, Engineering, and Medicine
This four page document presents the highlights from the 2019 National Academies report on medication assisted treatment for opioid use disorder. Funding Source: National Institute on Drug Abuse, National Institutes of Health; Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Medications for Opioid Use Disorder Save Lives: Consensus Study Report – Conclusions
Source: National Academies of Science, Engineering, and Medicine
This one page document summarizes the conclusions of the 2019 National Academies report on medications for opioid use disorder.